VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
VRPX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
VRPXVirpax Pharmaceuticals, Inc.
$0.01$47224
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksVRPXQuarterly Financials

Virpax Pharmaceuticals, Inc. (VRPX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Virpax Pharmaceuticals, Inc. (VRPX) quarterly income statement — complete revenue, gross profit & net income history

VRPX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20Q3'20Q2'20Q1'20
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold00000000000000000000
COGS % of Revenue--------------------
Gross Profit00000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses3.39M1.92M3.46M3.3M4.68M6.12M3.24M1.65M3.1M7.72M5.9M5.12M4.12M3.25M2.31M2.35M686.88K1.66M1.23M615.87K
OpEx % of Revenue--------------------
Selling, General & Admin2.29M780.96K1.5M1.69M3.59M4.62M1.95M415.45K1.74M4.91M2.65M1.78M2.37M1.55M1.99M1.27M582.6K810.67K1.06M448.99K
SG&A % of Revenue--------------------
Research & Development1.11M1.14M1.96M1.61M1.1M1.5M1.29M1.24M1.36M2.81M3.26M3.34M1.75M1.7M316.56K1.07M104.28K851.78K168.67K166.88K
R&D % of Revenue--------------------
Other Operating Expenses00000000073.25K19.37K-13.18K3.17K0-3.83K0-4K04K0
Operating Income-3.39M-1.92M-3.46M-3.3M-4.68M-6.12M-3.24M-1.65M-3.1M-7.72M-5.9M-5.12M-4.12M-3.25M-2.31M-2.35M-686.88K-1.66M-1.23M-615.87K
Operating Margin %--------------------
Operating Income Growth %27.53%68.53%-6.76%-100.02%-51%20.74%45.13%67.78%24.74%-137.41%-156.08%-118.17%-500.05%-95.48%-87.36%-281.35%-3.55%--18.91%
EBITDA-3.39M-1.91M-3.44M-3-3.77M0-234K0-2M00000000000
EBITDA Margin %--------------------
EBITDA Growth %9.98%--1369.77%--88.3%---------------
D&A (Non-Cash Add-back)010.65K19.13K3.3M918.1K6.12M3.01M1.65M1.1M7.72M5.9M5.12M4.12M3.25M2.31M2.35M686.88K1.66M1.23M615.87K
EBIT-3.39M-1.91M-3.44M-3.3M-5.93M-6.12M-3.11M-1.65M-2.99M-7.72M-5.9M-5.12M-4.12M-3.19M-2.31M-2.35M-686.88K-1.66M-1.23M-615.87K
Net Interest Income0-92.75K-11K0-130.53K000000-13.18K818-28.89K-34.05K-30.7K-18.33K-45.71K-43.26K-40.63K
Interest Income0000000000008180000000
Interest Expense092.75K11K0130.53K00000013.18K028.89K34.05K30.7K18.33K45.71K43.26K40.63K
Other Income/Expense4.65K-82.1K8.13K82.03K122.39K120.64K126.72K130.53K114.97K73.25K19.37K-13.18K3.99K34.03K-37.88K-30.7K-18.33K-45.71K-39.26K-40.63K
Pretax Income-3.39M-2.01M-3.45M-3.22M-4.56M-5.99M-3.11M-1.52M-2.99M-7.64M-5.88M-5.14M-4.12M-3.22M-2.34M-2.38M-705.21K-1.71M-1.27M-656.5K
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-3.39M-2.01M-3.45M-3.22M-4.56M-5.99M-3.11M-1.39M-2.87M-7.57M-5.87M-5.15M-4.12M-3.22M-2.34M-2.38M-705.21K-1.71M-1.27M-656.5K
Net Margin %--------------------
Net Income Growth %25.68%66.53%-10.84%-131.68%-58.83%20.8%46.93%73.01%30.25%-135.36%-150.29%-116.46%-483.89%-88.26%-84.55%-262.42%-0.74%--16.61%
Net Income (Continuing)-3.39M-2.01M-3.45M-3.22M-4.56M-5.99M-3.11M-1.52M-2.99M-7.64M-5.88M-5.14M-4.12M-3.22M-2.34M-2.38M-705.21K-1.71M-1.27M-656.5K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.80-0.43-1.75-2.75-3.89-5.12-2.66-1.19-2.45-0.65-0.50-0.44-0.62-0.53-0.47-0.60-0.16-0.38-0.26-0.13
EPS Growth %79.43%91.6%34.21%-131.09%-58.78%-687.69%-432%-170.45%-295.16%-22.64%-6.38%26.67%-287.5%-39.47%-80.77%-361.54%-14.29%--95.24%
EPS (Basic)-0.80-0.43-1.75-2.75-3.89-5.12-2.66-1.19-2.45-0.65-0.50-0.44-0.62-0.53-0.47-0.60-0.16-0.38-0.26-0.13
Diluted Shares Outstanding4.25M4.66M1.98M1.17M1.17M1.17M1.17M1.17M1.17M11.71M11.71M11.71M6.68M6.01M4.96M3.95M4.51M4.51M4.95M4.95M
Basic Shares Outstanding4.25M4.66M1.98M1.17M1.17M1.17M1.17M1.17M1.17M11.71M11.71M11.71M6.68M6.01M4.96M3.95M4.51M4.51M4.95M4.95M
Dividend Payout Ratio--------------------